$NTRB

Nutriband Inc. announced on September 21, 2026 that that its publicly traded warrants will expire in accordance with their original terms at 5:00 p.m

NutriBand Inc. (NTRB) filed an SEC Form 8-K — Regulation FD Disclosure. Item 7.01 Financial Statements and Exhibits Nutriband Inc. (“Nutriband” or the “Company”) announced on September 21, 2026 that that its publicly traded warrants (Nasdaq: NTRBW) will expire in accordance with their original terms at 5:00 p.m. Eastern Time on September 30, 2026. Tr

Original reporting
Published Sep 23, 2026, 9:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$NTRB
Neutral
high confidence
Mentioned
$NTRB
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NTRBNeutralLow
01

Why it matters

The warrants will cease trading on September 30, 2026, with no effect on the common stock (NTRB).

02

Market read

A routine corporate action with limited trading relevance.

03

What to watch

Potential short‑term volatility in warrant pricing before expiration.

Relevance 4/10Novelty 3/10Timing: expires September 30, 2026

Background

SEC Form 8‑K filing discloses the expiration terms of NutriBand's warrants (NTRBW).

Company-level read

Ticker impact

$NTRBNeutralHigh confidence
Context

NutriBand announced its publicly traded warrants will expire on September 30, 2026, ending trading thereafter.

Expected impact

No material impact on NTRB equity price expected.

Evidence & confidence

The filing is a routine corporate action with no change to the underlying shares.

Market effects

Minimal; warrants are a niche financing tool with limited sector impact.

None; the event is company‑specific.

None

Counterpoint

Investors could view the warrant expiration as a cleanup of dilutive potential.

Key entities

  • NutriBand Inc.

    Issuer of the warrants and common stock.

Related articles

$ASSTMed

Saylor Cheers Strive’s $280 Million Bitcoin Buy While Strategy Bought 85% Less - Strive (NASDAQ:ASST)

Strive (ASST) bought 3,311 Bitcoin for $280 million, its largest purchase since January, bringing total holdings to 32,773 BTC. CEO Matt Cole noted the purchase included $208 million in exercised warrants. Meanwhile, Strategy (MSTR) reduced its Bitcoin buying by 85% due to lower share sale proceeds and increased preferred-stock buybacks.

$GETYHighAI 9/10

Getty Images prepares to file for Chapter 11 bankruptcy

Getty Images, with 477 million assets and 600,000 photographers, plans to file for Chapter 11 bankruptcy and go private by 2026. The company reported $229.1M revenue in Q2 2026 and aims to eliminate $2.1B in debt. Koch Equity Development and the Getty family will invest $533M. A merger with Shutterstock failed due to antitrust concerns, and AI disruption has impacted demand. Subscribers declined from 321,000 to 241,000 in 2025. Getty will delist from the NYSE after shares fell below $1.

$GETYHighAI 9/10

Getty Images to file for bankruptcy as investors pledge $533 million rescue

Getty Images (NYSE:GETY) plans to file for Chapter 11 bankruptcy protection under a $533 million rescue deal to reduce debt and go private. Investors, including the Getty family and Koch Equity Development, will provide new equity, while creditors will eliminate $270 million in unsecured debt. The restructuring, expected to complete by 2026, will transfer 100% ownership to the investors, potentially leaving existing shareholders with no value.

$CIFRMed

Cipher Digital Sinks 12% on $850 Million Zero-Coupon Convertible Note Offering

Cipher Digital (CIFR) shares fell 12% after announcing an $850 million zero-coupon convertible note offering due 2032, with an option for $150 million more. The company plans to exchange part of its 1.75% 2030 notes for stock, adding to a 75% increase in diluted shares since 2021. Proceeds will partly fund capped calls to reduce dilution and support a $750 million equity investment in an AI lab project.